Polymyositis and dermatomyositis risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 20: | Line 20: | ||
*** Influenza | *** Influenza | ||
**Malignancy such as: | **Malignancy such as: | ||
*** Ovarian | *** Ovarian | ||
*** Lung | *** Lung | ||
| Line 27: | Line 26: | ||
*** Pancreatic | *** Pancreatic | ||
*** Non-Hodgkin’s lymphoma | *** Non-Hodgkin’s lymphoma | ||
**Drugs such as: | **Drugs such as: | ||
***Statins | ***Statins | ||
Revision as of 15:17, 5 April 2018
|
Polymyositis and dermatomyositis Microchapters |
|
Differentiating Polymyositis and dermatomyositis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polymyositis and dermatomyositis risk factors On the Web |
|
American Roentgen Ray Society Images of Polymyositis and dermatomyositis risk factors |
|
Risk calculators and risk factors for Polymyositis and dermatomyositis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Risk Factors
- Common risk factors in the development of polymyositis and dermatomyositis include .[1]
Common Risk Factors
- Common risk factors in the development of polymyositis and dermatomyositis include:
- Viral infections such as:
- Coxsackie B virus
- Parvovirus
- Enterovirus
- Human T-cell lymphotropic virus (HTLV-1)
- Human immunodeficiency virus (HIV)
- Epstein-Barr virus (EBV)
- Adenovirus
- Influenza
- Malignancy such as:
- Ovarian
- Lung
- Gastric
- Colorectal
- Pancreatic
- Non-Hodgkin’s lymphoma
- Drugs such as:
- Statins
- Viral infections such as:
Less Common Risk Factors
- Less common risk factors in the development of polymyositis and dermatomyositis include: